Although many PET tracers are in use, FDG still is the most widely used in clinical oncology practice. FDG therefore deserves an in-depth discussion, which is even more interesting because of the huge increase in the molecular biology of glucose metabolism. Obviously, other tracers are of increasing importance as well, and these will be discussed in short.
|Title of host publication||Molecular Radio-Oncology|
|Editors||Michael Baumann, Mechthild Krause, Nils Cordes|
|Publication status||Published - 2016|
|Series||Recent Results in Cancer Research|